共 53 条
[1]
Sledge GW(2014)Past, present, and future challenges in breast cancer treatment J Clin Oncol. 32 1979-1986
[2]
Mamounas EP(1978)Relationship between oestrogen-receptor content and histological grade in human primary breast tumours Br J Cancer. 38 745-748
[3]
Hortobagyi GN(1984)Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading Cancer. 54 2237-2242
[4]
Burstein HJ(2014)Neoadjuvant therapy in the treatment of breast cancer Surg Oncol Clin N Am. 23 505-523
[5]
Goodwin PJ(2005)Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis J Natl Cancer Inst. 97 188-194
[6]
Wolff AC(2012)Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer Ann Surg Oncol. 19 1508-1516
[7]
Maynard PV(1998)Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol. 16 2672-2685
[8]
Davies CJ(2006)Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol. 24 2019-2027
[9]
Blamey RW(2006)Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer Ann Surg. 244 464-470
[10]
Elston CW(2007)Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy J Clin Oncol. 25 4414-4422